Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Incidental gynecological findings on computed tomographic colonography: Prevalence and outcomes
Gynecologic Oncology, 09/15/09
Stitta IA et al. – Gynecologic extracolonic findings are common in women undergoing CTC. These gynecologic ECF identified on CTC may lead to additional investigative studies and procedures.
Methods- Electronic database identified female patients who underwent CTC at Walter Reed Army Medical Center from January 2002-July 2005.
- CTC reports pared down using gynecologic keywords
- Subsequent radiological studies and pathology reports evaluated for women with gynecological findings
- Gynecologic extracolonic findings (ECF) were identified in 71 (9.5%) of the 749 women who underwent CTC
- Of these 71 , 14 (20%) underwent additional radiological and/or surgical evaluation
- Nine (13%) of these women underwent surgical evaluation; all pathologic diagnoses were benign
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Hodgkin's lymphoma in remission after first-line therapy: Which patients need FDG-PET/CT for follow-up?
Annals of Oncology, 11/17/09
Ovarian cancer screening and early detection
Women's Health, 11/04/09
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Ovarian cancer screening and early detection
Women's Health, 11/04/09
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: A phase 3, open-label, randomised controlled trial
The Lancet, 11/23/09
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia
New England Journal of Medicine, 11/06/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


